» Articles » PMID: 24342978

Recipient Age and Risk for Mortality After Kidney Transplantation in England

Overview
Journal Transplantation
Specialty General Surgery
Date 2013 Dec 18
PMID 24342978
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to explore age-related mortality post-kidney transplantation in England over the last decade.

Methods: This study used data from Hospital Episode Statistics to select all kidney transplant procedures performed in England between April 2001 and March 2012. Demographics and medical comorbidities (based upon ICD-10 codes) were extracted at baseline. Data linkage analysis was performed with the Office for National Statistics to identify all deaths occurring among this study cohort.

Results: Data for 19,103 kidney transplant procedures was analyzed, with a median follow-up of 4.4 years (interquartile range 2.2-7.3 years). Categorization of age cohorts at time of transplantation were age below 50 (n=11,421, 59.8%), 50 to 59 (n=4,195, 22.0%), 60 to 69 (n=2,887, 15.1%), 70 to 79 (n=589, 3.1%), and 80 and above (n=11, 0.1%). There were 2,085 deaths that occurred among the study cohort during follow-up and mortality risk increased with age: below 50 (5.8%), 50 to 59 (14.2%), 60 to 69 (22.0%), 70 to 79 (31.9%), and 80 and above (45.5%). The three most common causes of deaths for recipients 70 and over were cardiac (21.2%), infection (21.2%), and malignancy (20.2%), respectively. Lower mortality was observed with the receipt of a living-donor kidney for recipients aged 70 and above. On Cox regression analysis, risk for death increased with each additional decade of recipient age over 50.

Conclusion: Increasing age is a strong, independent risk factor for death after kidney transplantation. Although lower mortality was observed with living kidney transplantation among elderly recipients, living-donor rates decrease with increasing recipient age. Pretransplant counseling and posttransplant tailored immunosuppression should be explored, the latter requiring targeted clinical trials.

Citing Articles

Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.

Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Bohmig G Transpl Int. 2025; 37:13886.

PMID: 39867871 PMC: 11758882. DOI: 10.3389/ti.2024.13886.


Long-Term Results of Kidney Transplantation in Patients Aged 60 Years and Older.

Ziaja J, Skrabaka D, Owczarek A, Widera M, Krol R, Kolonko A J Clin Med. 2025; 14(1.

PMID: 39797161 PMC: 11722099. DOI: 10.3390/jcm14010078.


Association between the age-adjusted Charlson Comorbidity Index and complications after kidney transplantation: a retrospective observational cohort study.

Huang Q, Luo T, Yang J, Lu Y, Zhou S, Hei Z BMC Nephrol. 2024; 25(1):457.

PMID: 39696100 PMC: 11654409. DOI: 10.1186/s12882-024-03888-1.


Unraveling complexity: morbidity factors in elderly kidney transplant recipients.

Gineste A, Malvezzi P, Jouve T, Millet C, Rostaing L, Noble J Clin Kidney J. 2024; 17(8):sfae182.

PMID: 39421236 PMC: 11483501. DOI: 10.1093/ckj/sfae182.


Debiased lasso for stratified Cox models with application to the national kidney transplant data.

Xia L, Nan B, Li Y Ann Appl Stat. 2023; 17(4):3550-3569.

PMID: 38106966 PMC: 10720921. DOI: 10.1214/23-aoas1775.